Featured on KFWB~NEWS TALK 980:
“Interviewed by Dr. Joe Chambers for the leading Los Angeles Talk Radio station, Dr. Shrewsbury explained why Defy Your DNA heralds an exciting time ahead as we enter the Golden Age of Medicine. Interview broadcast on Saturday, June 1st, 2013.”
“I Have just finished your book. I must say that I am very impressed. You have explained a difficult topic very effectively. I particularly enjoyed your clever use of analogy. The glossary was also very useful for those, like me, with older brains.
DNA is certainly a hot topic – apart from medical aspect which was your focus, there is also the whole field of genetic engineering. Unfortunately, people hold entrenched opinions about scientific subjects of which they obviously understand very little – as exemplified by the frequent misuse of the term “it’s in our DNA”! So, theoretically, there should be demand for books which explain genetics, genomics and pharmocogenomics etc. so lucidly. Your book certainly fills a much-needed gap.” Posted by John Hicks BVSc former Veterinarian and Author of Pizzles in Paradise and A Wander in Vetland on 18 June 2013 (Visit http://www.smashwords.com/profile/view/johnxvet)
“Duchenne enters the homes of families around the world. Parents, at first unable to grasp its meaning, seek information and advice on-line. By definition, parents and family members become advocates, explaining what Duchenne means, what is it, what might happen, and what they hope for. They explain over and over again, until the story becomes a regular conversation. Duchenne, the unwanted guest, follows them around. It impacts every activity, every plan, every waking moment. And they necessarily become experts about their son. But more is required of them. They necessarily become experts in genetics, learning about and understanding the genetic cause of their son’s Duchenne, understand what happens to muscle because the structural protein, dystrophin, is absent, and what targets are being explored that may have the potential to stop or reverse the pathology.
Families meet often on-line and in person to talk about Duchenne and what they might do to change the landscape, to expedite treatments for their son, for all the boys. Often, they have opportunities to meet with clinicians and researchers discussing complicated subjects as genetics, muscle physiology, targets, assays, animal studies, toxicology packages, clinical protocols. And often, especially those that are new to the world of Duchenne, they ask: “Is there a book I could read? Something that would expand my knowledge, something that might clarify, explain, describe what I should know?”
Dr. Shrewsbury’s book, Defy Your DNA, is that book”. Posted by Pat Furlong, Founding President and CEO, Parent Project Muscular Dystrophy on 26 March 2013
“Dr. Stephen Shrewsbury will enthrall you while explaining why your DNA is not your destiny. Read this book if you are a seasoned health professional. Read this book if you are curious about cutting edge scientific advances and want lucid explanations of gene therapy and more. Read this book if you have a loved one with a rare disease. Read it now.” – Posted by Nancy R. Katz, Ph.D. President & Principal Medical Writing Consultant, Illyria Consulting Group, Inc. on 15 March 2013
“Dr. Shrewsbury’s book is an important work that vividly portrays to the lay reader and scientific community the ongoing evolution of modern medicine from a broad perspective and with a detailed examination of the central role of modulation of gene expression and repair of faulty DNA.”
“An insightful and comprehensive historical perspective on the foundation of modern medicine and a visionary outlook on exciting developments in the field of nucleic acid-based therapeutics.” – Posted by Doug Kornbrust PhD, DABT President of Preclinsight on 30 January 2013
“I must say that the story reads very well. It reminds me of when I read Future Shock (by the futurist Avin Toffler) a long time ago – one can quickly absorb the salient points” – Posted by Dwight Weller PhD Former Professor of Chemistry at Oregon State University and now Senior Vice President of AVI BioPharma on 7 September 2011